UnitedHealth Group (NYSE:UNH) Trading Down 0%

UnitedHealth Group Incorporated (NYSE:UNH)’s share price fell 0% on Friday . The company traded as low as $570.36 and last traded at $576.86. 1,370,091 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 4,005,205 shares. The stock had previously closed at $577.07.

Analyst Ratings Changes

A number of brokerages have recently issued reports on UNH. Barclays increased their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Monday, September 16th. UBS Group raised their price target on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Finally, Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Price Performance

The firm’s 50 day simple moving average is $577.10 and its two-hundred day simple moving average is $520.80. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The firm has a market capitalization of $529.22 billion, a P/E ratio of 35.15, a P/E/G ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.14 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of UnitedHealth Group by 0.6% during the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock valued at $41,755,280,000 after purchasing an additional 544,740 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in UnitedHealth Group by 0.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after buying an additional 94,641 shares in the last quarter. Capital Research Global Investors boosted its holdings in UnitedHealth Group by 2.2% in the fourth quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after acquiring an additional 324,733 shares in the last quarter. Capital International Investors increased its holdings in shares of UnitedHealth Group by 4.8% during the fourth quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after acquiring an additional 542,424 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its position in UnitedHealth Group by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after purchasing an additional 35,533 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.